You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Remove Advisory bodies/Committees filter Advisory bodies/Committees (1)
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Remove Listed medicines filter Listed medicines (2)
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (7)
- Remove Scheduling filter Scheduling (85)
- Sunscreens (1) Apply Sunscreens filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (3) Apply Therapeutic goods regulation filter
- (-) Remove Prescription medicines filter Prescription medicines
- (-) Remove Listed medicines filter Listed medicines
- (-) Remove Advisory bodies/Committees filter Advisory bodies/Committees
- (-) Remove Scheduling filter Scheduling
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
Proposed new medical device classification for substances introduced into the body via a body orifice or applied to the skin
Closed on 29 April 2019
Proposed changes to the classification of active implantable medical devices and their accessories
Closed on 29 April 2019
Proposed changes to the classification of medical devices used in direct contact with the heart, central circulatory or central nervous systems
Closed on 29 April 2019
Targeted consultation: Review of chemical scheduling in relation to cosmetic and fragrance ingredients
Closed on 5 April 2019
Proposed criteria for Appendix M of the Poisons Standard to support rescheduling of substances from Schedule 4 (Prescription only) to Schedule 3 (Pharmacist only)
Closed on 1 April 2019
Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
Closed on 31 March 2019
Proposed reclassification of spinal implantable medical devices
Closed on 31 March 2019
Regulation of software, including Software as a Medical Device (SaMD)
Closed on 31 March 2019
Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia
Closed on 18 February 2019
Potential reclassification of active medical devices for diagnosis and patient therapy
Closed on 18 February 2019